MELISSA BOUFFARD: Open Payments
NPI 1033379961 · WARREN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,454 in 82 payments from 19 companies in 2025. Trend: 2023 $1,187 · 2024 $1,681 · 2025 $1,454
Food & beverage: $1,354Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $195 |
| LEO Pharma Inc. | 12 | $188 |
| UCB, Inc. | 11 | $183 |
| Incyte Corporation | 8 | $139 |
| Amgen Inc. | 7 | $117 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 6 | $109 |
| Galderma Laboratories, L.P. | 6 | $103 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $84 |
| ABBVIE INC. | 4 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
Products named: TREMFYA, Bimzelx, OPZELURA, ADBRY, Otezla, Cabtreo, AKLIEF, ANZUPGO.
Industry payments across NJ — which companies pay providers there.
